Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensitive nonradiometric method for determining thymidine kinase 1 activity.

Anders Ohrvik1, Maria Lindh, Roland Einarsson

  • 1DiaSorin AB, SE-161 02 Bromma, Sweden.

Clinical Chemistry
|July 13, 2004
PubMed
Summary

A new enzyme-labeled immunoassay accurately measures Thymidine Kinase 1 (TK1), a potential tumor marker. This precise assay shows promise for managing hematologic malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and economic impact of incisional negative pressure wound therapy in breast surgery: meta-analysis.

The British journal of surgery·2026
Same author

Magnetic seed versus guidewire-based breast cancer localization with magnetic lymph node detection: cost-minimization analysis.

The British journal of surgery·2025
Same author

Ultra-low dose superparamagnetic iron oxide nanoparticle injection for sentinel lymph node detection in breast cancer: prospective cohort study.

The British journal of surgery·2025
Same author

Plasma cholinergic markers are associated with post-stroke walking recovery-revisiting the STROKEWALK study.

Frontiers in neurology·2025
Same author

A novel cross-validated machine learning based Alertix-Cancer Risk Index for early detection of canine malignancies.

Frontiers in veterinary science·2025
Same author

ASO Visual Abstract: Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-Analysis of Tracer Uptake.

Annals of surgical oncology·2025

Area of Science:

  • Biochemistry
  • Clinical Diagnostics
  • Enzyme Assays

Background:

  • Thymidine Kinase 1 (TK1) is a cell proliferation marker with potential in tumor diagnostics.
  • Measuring serum TK1 is challenging due to differing physical properties compared to cytoplasmic TK1.
  • Existing methods face difficulties in specific TK1 determination.

Purpose of the Study:

  • To develop and validate a novel enzyme-labeled immunoassay for quantifying Thymidine Kinase 1 (TK1) in patient samples.
  • To assess the assay's precision, accuracy, and resistance to common interferences.
  • To evaluate the utility of the TK1 assay in the context of hematologic diseases.

Main Methods:

  • A competitive immunoassay was developed using 3'-azido-2',3'-deoxythymidine (AZT) phosphorylation by TK1.

Related Experiment Videos

  • AZT 5'-monophosphate (AZTMP) was detected using anti-AZTMP antibodies and a peroxidase-labeled conjugate.
  • Assay performance was validated against a TK radioenzyme assay (REA) using 78 hematologic disease patient samples.

    • Main Results:

    • The assay demonstrated a detection limit of 78 microIU/L with good within-run precision (CV <20% down to 130 microIU/L).
    • High specificity was observed, with TK2 activity cross-determination below 0.1%.
    • Excellent recovery (84-115%) and linearity were confirmed, with low inter-assay (3.5-7.4%) and intra-assay (4.1-9.1%) imprecision.

    Conclusions:

    • The developed TK1 enzyme-labeled immunoassay is precise, accurate, and robust against interferences.
    • The assay utilizes a stable substrate, offering a practical tool for clinical use.
    • This assay holds potential for improved management of hematologic malignancies.